Form S-1/A Tvardi Therapeutics,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20251007/A4BZ922C8Z22KJZZ27ZO2ZZZDPT9Z2R2ZV7Q
Filed on: October 7, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roche wins FDA clearance for vaginitis PCR diagnostic test
- FDA approves GSK lung cancer drug Jideytro ahead of schedule
- QumulusAI signs $18M deal to supply Nvidia Blackwell B300 nodes
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
